Evaluation of pathophysiology of cancer based on HLA and APRs.
Not Applicable
- Conditions
- Esophageal cancer Gastric cancer Colorectal cancer Liver cancer Pancreatic cancer Gallbladder and bili duct cancer Breast cancer Lung cancer
- Registration Number
- JPRN-UMIN000037478
- Lead Sponsor
- Japan cancer treatment and behavior study group (JCTB)
- Brief Summary
The frequencies of HLA A33, B44, Cw3, DR6, DR8, DR9 and DQ4 antigens were lower in total; therefore, these antigens may act as defensive factors of carcinogenesis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 967
Inclusion Criteria
Not provided
Exclusion Criteria
not particular
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method